Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis
Tuberculosis and Respiratory Diseases · 09.11.2026
DOI: 10.4046/trd.2026.0189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis and Respiratory Diseases, online erschienen am 09.11.2026. Verfasst von Sanjay Singhal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, India. drsanjaysinghal79@yahoo.co.in.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, India. drsanjaysinghal79@yahoo.co.in.
- Department of Pulmonary Medicine, All India Institute of Medical Sciences-Rajkot, India.
Zitieren
APA
Singhal, S., & Deokar, K. (2026). Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis. Tuberculosis and Respiratory Diseases. https://doi.org/10.4046/trd.2026.0189
Vancouver
Singhal S, Deokar K. Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis. Tuberculosis and Respiratory Diseases. 2026. doi:10.4046/trd.2026.0189
BibTeX
@article{Singhal2026,
author = {Singhal, Sanjay and Deokar, Kunal},
title = {Authors’ Response: Therapeutic Drug Monitoring of Linezolid and Prevention of Optic Neurotoxicity in Drug-Resistant Tuberculosis},
journal = {Tuberculosis and Respiratory Diseases},
year = {2026},
doi = {10.4046/trd.2026.0189}
}
EUVIMED